Debating the scope of a health research and development convention.
作者信息
Moran Mary
机构信息
Policy Cures, Level 10, 46 Market Street, Sydney, NSW 2000, Australia.
出版信息
Bull World Health Organ. 2013 Aug 1;91(8):618-20. doi: 10.2471/BLT.12.110486. Epub 2013 May 31.
Abstract
摘要
相似文献
1
Debating the scope of a health research and development convention.关于健康研发公约范围的辩论。
Bull World Health Organ. 2013 Aug 1;91(8):618-20. doi: 10.2471/BLT.12.110486. Epub 2013 May 31.
2
The Union's Ethics Advisory Group.欧盟伦理咨询小组。
Int J Tuberc Lung Dis. 2011 Jun;15 Suppl 2:1-2. doi: 10.5588/ijtld.11.0071.
3
Priorities and funding for global cancer surgery research.全球癌症手术研究的重点与资金投入
J Surg Oncol. 2017 Apr;115(5):513-516. doi: 10.1002/jso.24586. Epub 2017 Feb 15.
4
The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC).《2016年疫苗研发进展：世界卫生组织疫苗产品研发咨询委员会（PDVAC）特刊》
Vaccine. 2016 Jun 3;34(26):2863-2864. doi: 10.1016/j.vaccine.2016.04.041. Epub 2016 Apr 21.
5
Developing medicines in line with global public health needs: the role of the World Health Organization.根据全球公共卫生需求研发药物：世界卫生组织的作用
Camb Q Healthc Ethics. 2011 Apr;20(2):290-7. doi: 10.1017/S0963180110000940.
6
7
Improving global health: the need to think 'outside the box'!改善全球健康：需要跳出框框思考！
Monash Bioeth Rev. 2003 Apr;22(2):69-72. doi: 10.1007/BF03351392.
8
Meeting of the Strategic Advisory Group of Experts on immunization, April 2013 – conclusions and recommendations.免疫战略咨询专家组会议，2013年4月——结论与建议
Wkly Epidemiol Rec. 2013 May 17;88(20):201-6.
9
Access to essential medicines for children: the world health organization's global response.儿童基本药物的获取：世界卫生组织的全球应对措施
Clin Pharmacol Ther. 2007 Nov;82(5):503-5. doi: 10.1038/sj.clpt.6100395.
10
Essential medicines for the whole world.全球的基本药物。
Clin Pharmacol Ther. 2007 Nov;82(5):500-3. doi: 10.1038/sj.clpt.6100388.
引用本文的文献
1
International Clinical Trials in Latin American and Caribbean Countries: Research and Development to Meet Local Health Needs.拉丁美洲和加勒比国家的国际临床试验：满足当地卫生需求的研究与开发。
Front Pharmacol. 2018 Jan 5;8:961. doi: 10.3389/fphar.2017.00961. eCollection 2017.
2
The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.卫生研发（R&D）的供需不匹配：问题概述、原因和解决方案。
Glob Health Action. 2013 Oct 10;6:22450. doi: 10.3402/gha.v6i0.22450.
本文引用的文献
1
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.1990 - 2020年按病因划分的死亡率和残疾率的替代预测：全球疾病负担研究
Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.
Zotero 插件